Salmeterol xinafoate
Serevent (salmeterol xinafoate) is a small molecule pharmaceutical. Salmeterol xinafoate was first approved as Serevent on 1994-02-04. It is used to treat asthma and bronchial spasm in the USA. It is known to target beta-2 adrenergic receptor.
| Trade Name | Serevent |
|---|---|
| Common Name | Salmeterol xinafoate |
| Indication | asthma, bronchial spasm |
| Drug Class | Bronchodilators (phenethylamine derivatives); anti-inflammatory agents (salicylic acid derivatives) |
